Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study.

作者: F Latteri , L Sandonato , V Di Marco , P Parisi , G Cabibbo

DOI: 10.1016/J.DLD.2007.12.021

关键词:

摘要: Abstract Background Neoplastic seeding of hepatocellular carcinoma may arise after radiofrequency ablation. Aims In order to clarify the real risk seeding, we observed a prospective cohort patients undergoing Methods Ninety-three (22.9%) out 406 consecutive with superimposed cirrhosis diagnosed at our Liver Unit (2000–2005) were selected for ablation according Barcelona 2000 EASL guidelines. Seventy-one treated by percutaneous approach and 22 laparotomy. After ultrasound scan was repeated every 3 months spiral-computed tomography 6 months. Results Overall 145 sessions performed in 93 patients: 113 (77.9%) 32 (22.1%) The median follow-up 23 (range 1–60). Only 1 71 (1.4%; 95% C.I. 0.25–7.56) percutaneously none (0%; 0–14.8) laparotomy showed neoplastic seeding. Conclusion experience small (1.1% per patient, 0.19–5.84; 0.7% procedure, 0.12–3.80). A stringent selection retraction needle hot tip have been instrumental obtaining this low frequency.

参考文章(29)
P. M. LOPEZ, A. VILLANUEVA, J. M. LLOVET, Systematic review: evidence‐based management of hepatocellular carcinoma – an updated analysis of randomized controlled trials Alimentary Pharmacology & Therapeutics. ,vol. 23, pp. 1535- 1547 ,(2006) , 10.1111/J.1365-2036.2006.02932.X
François Durand, Jean Marc Regimbeau, Jacques Belghiti, Alain Sauvanet, Valérie Vilgrain, Benoı̂t Terris, Vincent Moutardier, Olivier Farges, Dominique Valla, Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma Journal of Hepatology. ,vol. 35, pp. 254- 258 ,(2001) , 10.1016/S0168-8278(01)00108-8
Shuichiro Shiina, Takuma Teratani, Shuntaro Obi, Shinpei Sato, Ryosuke Tateishi, Tomonori Fujishima, Takashi Ishikawa, Yukihiro Koike, Haruhiko Yoshida, Takao Kawabe, Masao Omata, A Randomized Controlled Trial of Radiofrequency Ablation With Ethanol Injection for Small Hepatocellular Carcinoma Gastroenterology. ,vol. 129, pp. 122- 130 ,(2005) , 10.1053/J.GASTRO.2005.04.009
Margarita Sala, Josep M. Llovet, Ramon Vilana, Lluís Bianchi, Manel Solé, Carmen Ayuso, Concepció Brú, Jordi Bruix, , Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma Hepatology. ,vol. 40, pp. 1352- 1360 ,(2004) , 10.1002/HEP.20465
B. Jason Bowles, Safety and Efficacy of Radiofrequency Thermal Ablation in Advanced Liver Tumors Archives of Surgery. ,vol. 136, pp. 864- 869 ,(2001) , 10.1001/ARCHSURG.136.8.864
Thomas F. Wood, D. Michael Rose, Mathew Chung, David P. Allegra, Leland J. Foshag, Anton J. Bilchik, Radiofrequency ablation of 231 unresectable hepatic tumors: Indications, limitations, and complications Annals of Surgical Oncology. ,vol. 7, pp. 593- 600 ,(2000) , 10.1007/BF02725339
Jordi Bruix, Morris Sherman, Josep M Llovet, Michel Beaugrand, Riccardo Lencioni, Andrew K Burroughs, Erik Christensen, Luigi Pagliaro, Massimo Colombo, Juan Rodés, None, Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference Journal of Hepatology. ,vol. 35, pp. 421- 430 ,(2001) , 10.1016/S0168-8278(01)00130-1
S. H. Kim, H. K. Lim, W. J. Lee, J. M. Cho, H.-J. Jang, Needle-tract implantation in hepatocellular carcinoma: frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun. Abdominal Imaging. ,vol. 25, pp. 246- 250 ,(2000) , 10.1007/S002610000025
Jeffrey D. Jaskolka, Murray R. Asch, John R. Kachura, Chia S. Ho, Marc Ossip, Florence Wong, Morris Sherman, David R. Grant, Paul D. Greig, Steven Gallinger, Needle tract seeding after radiofrequency ablation of hepatic tumors. Journal of Vascular and Interventional Radiology. ,vol. 16, pp. 485- 491 ,(2005) , 10.1097/01.RVI.0000151141.09597.5F
Ronnie Tung-Ping Poon, Kelvin Kwok-Chai Ng, Chi-Ming Lam, Victor Ai, Jimmy Yuen, Sheung-Tat Fan, Radiofrequency ablation for subcapsular hepatocellular carcinoma. Annals of Surgical Oncology. ,vol. 11, pp. 281- 289 ,(2004) , 10.1245/ASO.2004.08.018